069620.KS
Daewoong pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 111,300.00
+2.20%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 445.1B
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- KRW 1.7K
- EPS estimate
- —
- Revenue actual
- KRW 424.4B
- Revenue estimate
- KRW 406.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | — | KRW 1.7K | — | KRW 424.4B |
| May 12, 2026 | — | KRW 2.2K | — | KRW 377.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026